{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T21:55:19Z","timestamp":1767995719399,"version":"3.49.0"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>In observational studies, circulating vascular endothelial growth factor (VEGF) has been reported to be associated with certain types of cancer. The purpose of this study was to verify whether there is a causal relationship between circulating VEGF and different types of cancer and the direction of the causal relationship. Summary statistical data were obtained from the corresponding genome-wide association studies (GWASs) to investigate the causal relationship between circulating VEGF and the risk of several cancers, including breast cancer, ovarian cancer, lung cancer, colorectal cancer, anus and anal canal cancer, prostate cancer, esophageal cancer, kidney cancer, bladder cancer, thyroid cancer, malignant neoplasm of the brain and malignant neoplasm of the liver and intrahepatic bile ducts. A two-sample bidirectional Mendelian randomization (MR) analysis and sensitivity tests were used to evaluate the validity of causality. A causal relationship was detected between circulating VEGF and colorectal cancer (OR 1.21, 95% CI 1.11\u20131.32, <jats:italic>p<\/jats:italic> &amp;lt; 0.000) and colon adenocarcinoma (OR 1.245, 95% CI 1.10\u20131.412, <jats:italic>p<\/jats:italic> &amp;lt; 0.000). Suggestive evidence of association was detected in VEGF on malignant neoplasms of the rectum (OR 1.16, 95% CI 1.00\u20131.34, <jats:italic>p<\/jats:italic> = 0.049). No causal relationship was found between circulating VEGF and other types of cancer, nor was there a reverse causal relationship from tumors to VEGF (<jats:italic>p<\/jats:italic> &amp;gt; 0.05). Circulating VEGF has a causal relationship with specific types of cancer. Our findings highlight and confirm the importance of circulating VEGF in the prevention and treatment of colorectal cancer.<\/jats:p>","DOI":"10.3389\/fgene.2022.981032","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T05:29:56Z","timestamp":1662528596000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Circulating vascular endothelial growth factor and cancer risk: A bidirectional mendelian randomization"],"prefix":"10.3389","volume":"13","author":[{"given":"Hong","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianjun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongli","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ajhg.2016.11.007","article-title":"Genome-wide association study identifies 27 loci influencing concentrations of circulating cytokines and growth factors","volume":"100","author":"Ahola-Olli","year":"2017","journal-title":"Am. J. Hum. Genet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10549-018-4882-z","article-title":"The clinical relevance of serum vascular endothelial growth factor (VEGF) in correlation to circulating tumor cells and other serum biomarkers in patients with metastatic breast cancer","volume":"172","author":"Banys-Paluchowski","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1290741","DOI":"10.1080\/19932820.2017.1290741","article-title":"The effect of vascular endothelial growth factor-1 expression on survival of advanced colorectal cancer patients","volume":"12","author":"Bendardaf","year":"2017","journal-title":"Libyan J. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1634\/theoncologist.2012-0190","article-title":"T reatment patterns and clinical outcomes in patients with metastatic colorectal cancer initially treated with FOLFOX-bevacizumab or FOLFIRI-bevacizumab: results from ARIES, a bevacizumab observational cohort study","volume":"17","author":"Bendell","year":"2012","journal-title":"Oncologist"},{"key":"B5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1470-2045(12)70477-1","article-title":"Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial.","volume":"14","author":"Bennouna","year":"2013","journal-title":"Lancet. Oncol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"","journal-title":"Genet. Epidemiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1093\/ije\/dyw220","article-title":"Assessing the suitability of summary data for two-sample mendelian random-ization analyses using MR-egger regression: the role of the I2 statistic","volume":"45","author":"Bowden","year":"","journal-title":"Int. J. Epidemiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"4680","DOI":"10.1158\/1078-0432.CCR-09-0192","article-title":"Vascular endothelial growth factor polymorphisms and esophageal cancer prognosis","volume":"15","author":"Bradbury","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1002\/sim.6835","article-title":"Combining information on multiple instrumental variables in mendelian randomization: comparison of allele score and summarized data methods","volume":"35","author":"Burgess","year":"2016","journal-title":"Stat. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1002\/sim.4197","article-title":"Bias in causal estimates from Mendelian randomization studies with weak instruments","volume":"30","author":"Burgess","year":"2011","journal-title":"Stat. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from Mendelian randomization using the MR-Egger method","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur. J. Epidemiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/s0025-7753(04)74197-4","article-title":"Serum vascular endothelial growth factor levels in patients with colorectal cancer and its prognostic significance","volume":"122","author":"Cubo","year":"2004","journal-title":"Med. Clin. Barc."},{"key":"B13","doi-asserted-by":"publisher","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading mendelian randomisation studies: a guide, glossary, and checklist for clinicians","volume":"362","author":"Davies","year":"2018","journal-title":"BMJ"},{"key":"B14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2147\/ott.s5256","article-title":"Anti-angiogenesis therapies: their potential in cancer management","volume":"3","author":"Eichholz","year":"2010","journal-title":"Onco. Targets. Ther."},{"key":"B15","doi-asserted-by":"publisher","first-page":"170","DOI":"10.4103\/1319-3767.80378","article-title":"Clinical relevance of serum vascular endothelial growth factor and interleukin-6 in patients with colorectal cancer","volume":"17","author":"Eldesoky","year":"2011","journal-title":"Saudi J. Gastroenterol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.4251\/wjgo.v9.i2.78","article-title":"Prognostic significance of vascular endothelial growth factor polymorphisms in colorectal cancer patients","volume":"9","author":"Esp\u00edrito Santo","year":"2017","journal-title":"World J. Gastrointest. Oncol."},{"key":"B17","first-page":"5731","article-title":"HIF-1alpha-mediated up-regulation of vascular endothelial growth factor, independent of basic fibroblast growth factor, is important in the switch to the angiogenic phenotype during early tumorigenesis","volume":"61","author":"Fang","year":"2001","journal-title":"Cancer Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/s42255-020-00287-2","article-title":"Genomic and drug target evaluation of 90 cardiovascular proteins in 30, 931 individuals","volume":"2","author":"Folkersen","year":"2020","journal-title":"Nat. Metab."},{"key":"B20","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/427787a","article-title":"Cancer without disease","volume":"427","author":"Folkman","year":"2004","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1572-0241.1998.00249.x","article-title":"Circulating vascular endothelial growth factor in patients with colorectal cancer","volume":"93","author":"Fujisaki","year":"1998","journal-title":"Am. J. Gastroenterol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1097\/IGC.0000000000001006","article-title":"Vascular endothelial growth factor (VEGF) polymorphisms and serum VEGF levels in women with epithelial ovarian cancer, benign tumors, and healthy ovaries","volume":"27","author":"Gonz\u00e1lez-Palomares","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"key":"B23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/09674845.2012.12002440","article-title":"Quantification of tumour and circulating vascular endothelial growth factor (VEGF) in patients with oesophagogastric cancer: a long-term follow-up study","volume":"69","author":"Gray","year":"2012","journal-title":"Br. J. Biomed. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nrclinonc.2009.110","article-title":"Targeting angiogenesis: Progress with anti-VEGF treatment with large molecules","volume":"6","author":"Grothey","year":"2009","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"5326","DOI":"10.1200\/JCO.2008.16.3212","article-title":"Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: Results from a large observational cohort study (BRiTE)","volume":"26","author":"Grothey","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1200\/JCO.2007.13.5947","article-title":"VEGF polymorphisms and survival in early-stage non-small-cell lung cancer","volume":"26","author":"Heist","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e34408","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome","volume":"7","author":"Hemani","year":"2018","journal-title":"Elife"},{"key":"B28","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41588-018-0286-6","article-title":"Discovery of common and rare genetic risk variants for colorectal cancer","volume":"51","author":"Huyghe","year":"2019","journal-title":"Nat. Genet."},{"key":"B29","doi-asserted-by":"publisher","first-page":"E60","DOI":"10.1002\/mc.21980","article-title":"Association of VEGF and KDR single nucleotide polymorphisms with colorectal cancer susceptibility in Koreans","volume":"52","author":"Jang","year":"2013","journal-title":"Mol. Carcinog."},{"key":"B30","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1186\/1471-2407-14-881","article-title":"Interplay between 3'-UTR polymorphisms in the vascular endothelial growth factor (VEGF) gene and metabolic syndrome in determining the risk of colorectal cancer in Koreans","volume":"14","author":"Jeon","year":"2014","journal-title":"BMC Cancer"},{"key":"B31","doi-asserted-by":"publisher","first-page":"6065","DOI":"10.3892\/ol.2018.9358","article-title":"Serum vascular endothelial growth factor-C levels predict lymph node metastasis and prognosis of patients with gallbladder cancer","volume":"16","author":"Jiang","year":"2018","journal-title":"Oncol. Lett."},{"key":"B32","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1158\/1078-0432.CCR-07-1537","article-title":"Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer","volume":"14","author":"Kim","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1097\/IGC.0000000000001027","article-title":"Serum vascular endothelial growth factor-A as a prognostic biomarker for epithelial ovarian cancer","volume":"27","author":"Komatsu","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"key":"B34","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/1471-2407-10-203","article-title":"Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer","volume":"10","author":"Kwon","year":"2010","journal-title":"BMC Cancer"},{"key":"B35","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature24284","article-title":"Association analysis identifies 65 new breast cancer risk loci","volume":"551","author":"Michailidou","year":"2017","journal-title":"Nature"},{"key":"B36","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s41588-020-0631-4","article-title":"Mendelian randomization accounting for correlated and uncorrelated pleiotropic effects using genome-wide summary statistics","volume":"52","author":"Morrison","year":"2020","journal-title":"Nat. Genet."},{"key":"B37","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0304-3835(02)00681-x","article-title":"The significance of circulating vascular endothelial growth factor (VEGF) protein in gastric cancer","volume":"192","author":"Ohta","year":"2003","journal-title":"Cancer Lett."},{"key":"B38","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/ng.3826","article-title":"Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer","volume":"49","author":"Phelan","year":"2017","journal-title":"Nat. Genet."},{"key":"B39","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s12032-014-0193-3","article-title":"Investigating the association of vascular endothelial growth factor polymorphisms with breast cancer: a Moroccan case-control study","volume":"31","author":"Rahoui","year":"2014","journal-title":"Med. Oncol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.3892\/mmr.2014.1890","article-title":"Vascular endothelial growth factor polymorphisms affect gene expression and tumor aggressiveness in patients with breast cancer","volume":"9","author":"Sa-Nguanraksa","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1007\/s10147-019-01495-x","article-title":"Serum vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 as prognostic biomarkers for uterine cervical cancer","volume":"24","author":"Sawada","year":"2019","journal-title":"Int. J. Clin. Oncol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e0120758","DOI":"10.1371\/journal.pone.0120758","article-title":"A multivariate genome-wide association analysis of 10 LDL subfractions, and their response to statin treatment, in 1868 Caucasians","volume":"10","author":"Shim","year":"2015","journal-title":"PLoS One"},{"key":"B43","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1001\/jama.292.8.972","article-title":"Modulating angiogenesis: more vs less","volume":"292","author":"Sivakumar","year":"2004","journal-title":"JAMA"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ije\/dyg070","article-title":"Mendelian randomization\u2019: can genetic epidemiology contribute to understanding environmental determinants of disease?","volume":"32","author":"Smith","year":"2003","journal-title":"Int. J. Epidemiol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1002\/jso.20619","article-title":"Vascular endothelial growth factor polymor-phisms in gastric cancer development, prognosis, and survival","volume":"94","author":"Tzanakis","year":"2006","journal-title":"J. Surg. Oncol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat. Genet."},{"key":"B47","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/path.1473","article-title":"Are tumours angiogenesis-dependent?","volume":"202","author":"Verheul","year":"2004","journal-title":"J. Pathol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/ng.3002","article-title":"Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer","volume":"46","author":"Wang","year":"2014","journal-title":"Nat. Genet."},{"key":"B49","first-page":"713","article-title":"The effect and mechanism of vascular endothelial growth factor (VEGF) on tumor angiogenesis in gallbladder carcinoma","volume":"48","author":"Xu","year":"2019","journal-title":"Iran. J. Public Health"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e0174140","DOI":"10.1371\/journal.pone.0174140","article-title":"KRAS and VEGF gene 3'-UTR single nucleotide polymorphisms predicted susceptibility in colorectal cancer","volume":"12","author":"Yang","year":"2017","journal-title":"PLoS One"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1093\/ije\/dyx034","article-title":"Mendelian Randomization: an R package for performing Mendelian randomization analyses using summarized data","volume":"46","author":"Yavorska","year":"2017","journal-title":"Int. J. Epidemiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1089\/gtmb.2012.0266","article-title":"Vascular endothelial growth factor (VEGF) gene polymorphisms and colorectal cancer: a meta-analysis of epidemiologic studies","volume":"16","author":"Zhao","year":"2012","journal-title":"Genet. Test. Mol. Biomarkers"},{"key":"B53","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.cyto.2014.11.009","article-title":"Relationship of common vascular endothelial growth factor polymorphisms and haplotypes with the risk of cervical cancer in Tunisians","volume":"74","author":"Zidi","year":"2015","journal-title":"Cytokine"}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.981032\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T05:30:06Z","timestamp":1662528606000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.981032\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,7]]},"references-count":53,"alternative-id":["10.3389\/fgene.2022.981032"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2022.981032","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,7]]},"article-number":"981032"}}